BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1690 related articles for article (PubMed ID: 15060191)

  • 1. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS; Brent RL
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing risks.
    Kasamatsu T; Kohda K
    Regul Toxicol Pharmacol; 2006 Oct; 46(1):100-4. PubMed ID: 16843577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saving lives and changing family histories: appropriate counseling of pregnant women and men and women of reproductive age, concerning the risk of diagnostic radiation exposures during and before pregnancy.
    Brent RL
    Am J Obstet Gynecol; 2009 Jan; 200(1):4-24. PubMed ID: 19121655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of drug use in pregnancy: prevention of birth defects.
    Peters PW
    Ann Ist Super Sanita; 1993; 29(1):131-7. PubMed ID: 8129259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of opiate, cocaine, and cannabis use.
    Hutchings DE; Dow-Edwards D
    Clin Perinatol; 1991 Mar; 18(1):1-22. PubMed ID: 1645632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
    Int J Toxicol; 2005; 24 Suppl 2():21-50. PubMed ID: 16154914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for gender differences in human and animal toxicology.
    Gochfeld M
    Environ Res; 2007 May; 104(1):4-21. PubMed ID: 16616135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive and teratologic effects of low-frequency electromagnetic fields: a review of in vivo and in vitro studies using animal models.
    Brent RL
    Teratology; 1999 Apr; 59(4):261-86. PubMed ID: 10331529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric pharmacokinetic data: implications for environmental risk assessment for children.
    Ginsberg G; Hattis D; Miller R; Sonawane B
    Pediatrics; 2004 Apr; 113(4 Suppl):973-83. PubMed ID: 15060190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicokinetics in the National Toxicology Program.
    Goehl TJ
    NIDA Res Monogr; 1997; 173():273-304. PubMed ID: 9260193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.